Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
Oliver William ScottSandar Tin TinJ Mark ElwoodAlana CavadinoLaurel A HabelMarion Kuper-HommelIan CampbellRoss LawrensonPublished in: Breast cancer research and treatment (2022)
Our findings suggest that any increased risk associated with BB use may be driven by risk in the initial few months of use. Long-term BB use may be associated with a reduction in BCD.